If you liked this article you might like

Bristol Myers-Squibb, Merck, Synergy Pharmaceuticals: Doug Kass' Views
Synergy Pharmaceuticals Secures Approval for Linzess Competitor
Futures, Asia Mixed as Investors Ponder the New President
Biotech Sector to See M&A, Earnings Action